Print

Print


I am looking for papers referring to the consequences in policy and clinical practice with the choice of prescription by GPs substitution drugs (methadone, Buprenorphine, Naltrexone etc).   
<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />